- The 8 States Most Likely to Legalize Marijuana Next
- Behind Russia's Current Crisis: It's Not the Ruble, It's Putin
- The Least Educated States in America
- Apple (AAPL) Stock Declining Today Amid Allegations of Poor Working Conditions in China
- BlackBerry (BBRY) Stock Declines Ahead of Upcoming Earnings Release
Iclusig may find use in other cancers and '113 is better than the market believes.
Through four reverse stock splits, Cell Therapeutics has lost 99% of its value.
Instead of selling stock whenever the wind blows, biotech execs should be buying.
The strange but true tale of a beleaguered, bankrupt biotech firm with 100 quadrillion shares outstanding.
How best to invest in the next important clinical trial catalyst facing Celgene.